These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8327031)

  • 1. [Anomalies of lipoprotein metabolism in chronic renal insufficiency].
    Lacour B; Massy ZA; Jungers P; Drueke T
    Nephrologie; 1993; 14(2):75-90. PubMed ID: 8327031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
    Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
    Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in factors that alter lipid metabolism in chronic renal failure.
    Drüeke T; Lacour B; Roullet JB; Funck-Brentano JL
    Kidney Int Suppl; 1983 Dec; 16():S134-8. PubMed ID: 6588243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and apolipoproteins change during the progression of chronic renal failure.
    Bergesio F; Monzani G; Ciuti R; Serruto A; Benucci A; Frizzi V; Salvadori M
    Clin Nephrol; 1992 Nov; 38(5):264-70. PubMed ID: 1451339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of lipoproteins with analytical capillary isotachophoresis.
    Schmitz G; Möllers C
    Electrophoresis; 1994 Jan; 15(1):31-9. PubMed ID: 8143678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of apolipoproteins in lipid metabolism].
    Karádi I; Kostner GM
    Ther Umsch; 1990 Jun; 47(6):467-74. PubMed ID: 2165281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new precipitation procedure for estimating high density lipoprotein cholesterol: precipitation of apolipoprotein B associated cholesterol with concanavalin A.
    Pascal M; Wülfert E
    Ann Biol Clin (Paris); 1981; 39(6):343-50. PubMed ID: 7325424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen.
    Farish E; Barnes JF; Fletcher CD; Ekevall K; Calder A; Hart DM
    Menopause; 1999; 6(2):98-104. PubMed ID: 10374215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
    Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
    Averna MR; Barbagallo CM; Di Paola G; Labisi M; Pinna G; Marino G; Dimita U; Notarbartolo A
    Biol Neonate; 1991; 60(3-4):187-92. PubMed ID: 1797121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein profile in patients with isolated hyperuricemia].
    Tinahones FJ; C-Soriguer FJ; González-Ruiz A; Ruano TJ; Pareja A; Collantes E
    An Med Interna; 1996 Oct; 13(10):483-6. PubMed ID: 9019194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lp(a) levels: effects of progressive chronic renal failure and dietary manipulation.
    Monzani G; Bergesio F; Ciuti R; Ciciani AM; Martinelli F; Rosati A; Salvadori M
    J Nephrol; 1997; 10(1):41-5. PubMed ID: 9241624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure].
    Tornero F; García-Garzón A; Rincón B; Prieto S; Usón J; Lozano L
    Nefrologia; 2000; 20(1):47-53. PubMed ID: 10822722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.